Inventor · disambiguated record
Donald Johns
Also filed as: JOHNS DONALD · JOHNS DONALD R
9 granted patents·17 pending applications·4 citations·filing 2007–2024
79Inventor score
Top patents by PatentIndex Score
26 records- 0176US2025032042A1Methods for evaluating patientsBIOGEN MA INC·Filed 2024·Application pending·0 cites
- 0273US12215387B2Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2022·Granted Feb 4, 2025·0 cites·20 claims
- 0372US11369603B2Use of a H3R inverse agonist for the treatment of shift work disorderNOVARTIS AG·Filed 2018·Granted Jun 28, 2022·1 cites·12 claims
- 0472US11096916B2Use of nicotinic acetylcholine receptor alpha 7 activatorsNOVARTIS AG·Filed 2019·Granted Aug 24, 2021·0 cites·6 claims
- 0571US2023337967A1Methods for evaluating patientsBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 0669US12201612B2Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol useNOVARTIS AG·Filed 2018·Granted Jan 21, 2025·1 cites·13 claims
- 0769US11878001B2Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine useNOVARTIS AG·Filed 2018·Granted Jan 23, 2024·1 cites·13 claims
- 0867US9828642B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2015·Granted Nov 28, 2017·1 cites·11 claims
- 0966US2022211679A1Alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1065US2021338621A1Use of nicotinic acetylcholine receptor alpha 7 activatorsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1162US11359241B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2017·Granted Jun 14, 2022·0 cites·8 claims
- 1262US2022039739A1Methods for evaluating patientsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1361US11311525B2Use of alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2017·Granted Apr 26, 2022·0 cites·9 claims
- 1459US2009281194A1Combinations for treating HIV-associated painJOHNS DONALD·Filed 2009·Application pending·0 cites
- 1556US2022184073A1Use of a h3r inverse agonist for the treatment of shift work disorderNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1654US2010041641A1Uses of metabotropic glutamate receptorsRALF GLATTHAR·Filed 2007·Application pending·0 cites
- 1750US2014187600A1Use of metabotropic glutamate receptorsGLATTHAR RALF·Filed 2014·Application pending·0 cites
- 1850US2015313884A1Use of alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 1949US2011212980A1Combinations for the treatment of migraineNOVARTIS AG·Filed 2009·Application pending·0 cites
- 2048US2014163050A1Use of 1H-quinazoline-2,4-dionesJOHNS DONALD·Filed 2014·Application pending·0 cites
- 2146US2021379062A1The use of a H3R inverse agonist for the treatment of excessive daytime sleepiness associated with parkinson's disease (PD)NOVARTIS AG·Filed 2019·Application pending·0 cites
- 2246US2012309742A1Use of metabotropic glutamate receptorsGLATTHAR RALF·Filed 2012·Application pending·0 cites
- 2344US10537539B2Use of nicotinic acetylcholine receptor alpha 7 activatorsDI PAOLO THERESE·Filed 2010·Granted Jan 21, 2020·0 cites·5 claims
- 2441US2013090346A1Use of 1H-quinazoline-2,4-dionesJOHNS DONALD·Filed 2012·Application pending·0 cites
- 2535US2014171448A1Use of nicotinic acetylcholine receptor alpha 7 activatorsFEUERBACH DOMINIK·Filed 2012·Application pending·0 cites
- 2633US2013052644A1Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS)GOMEZ-MANCILLA BALTAZAR·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donald Johns files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →